Soluble FceRI is a potential biomarker for poor therapeutic response to omalizumab in patients with chronic spontaneous urticaria S. Moino-Romero,P. Kolkhir,Z. Szepfalusi,M. Maurer,S. AltrichterEXPERIMENTAL DERMATOLOGY(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要